Gail Model for Breast Cancer Risk

ورودی‌های بالینی بیمار

حداقل ۳۵ — حداکثر ۸۵ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
five year risk
—percentage
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–1.67
  • High Risk1.67–100
Direct Clinical Answer

The Gail Model for Breast Cancer Risk calculator is designed for bedside calculating a woman's absolute risk of developing invasive breast cancer over the next 5 years and up to age 90 (lifetime risk) using personal medical and reproductive history and family history of breast.

Clinical Guidelines & Evidence

Estimates risk for breast cancer based on demographic and clinical data. The Gail Model calculates a woman's absolute risk of developing invasive breast cancer over the next 5 years and up to age 90 (lifetime risk) using personal medical and reproductive history and family history of breast cancer among first-degree relatives.

Clinical Indication

The Gail Model for Breast Cancer Risk is indicated for bedside clinical practice to support Estimates risk for breast cancer based on demographic and clinical data. The Gail Model calculates a woman's absolute risk of developing invasive breast cancer over the next 5 years and up to age 90 (lifetime risk) using personal medical and reproductive history and family history of breast cancer among first-degree relatives.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.

Formula & Variables:

Complex statistical model using logistic regression with race-specific coefficients for age, age at menarche, age at first live birth, number of first-degree relatives with breast cancer, number of breast biopsies, and presence of atypical hyperplasia.

Input Parameters

NameTypeRequiredDescription
ageintegerYesCurrent age of the woman(years)
age_at_menarchestringYesAge at first menstrual period(years)
age_at_first_birthstringYesAge at first live birth or nulliparous status(years)
relatives_with_breast_cancerstringYesNumber of first-degree relatives (mother, sisters, daughters) with breast cancer
previous_biopsiesstringYesNumber of previous breast biopsies
atypical_hyperplasiastringYesHistory of atypical hyperplasia on breast biopsy (only relevant if previous biopsies ≥1)
race_ethnicitystringYesRace/ethnicity for risk adjustment
asian_subracestringNoAsian-American sub-race (only required if race_ethnicity is asian_american)

Score Interpretation & Guidance

RangeStageDescription
0–1.67Low RiskLow risk for breast cancer
1.67–100High RiskHigh risk for breast cancer

Evidence-Based References (EBM)

  • Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-86. doi: 10.1093/jnci/81.24.1879.DOI: 10.1093/jnci/81.24.1879
  • Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91(18):1541-8. doi: 10.1093/jnci/91.18.1541.DOI: 10.1093/jnci/91.18.1541
  • Matsuno RK, Costantino JP, Ziegler RG, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011;103(12):951-61. doi: 10.1093/jnci/djr154.DOI: 10.1093/jnci/djr154

Related calculators